Request Demo
Last update 26 Oct 2025
QR-12000
Last update 26 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms QR 12000, QR12000 |
Target |
Action antagonists, inhibitors |
Mechanism AT2R antagonists(Angiotensin II receptor type 2 antagonists), enkephalinase inhibitors(Neprilysin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
12
Clinical Trials associated with QR-12000CTR20253458
QR12000复方片在肾功能不全和肾功能正常参与者中的药代动力学和安全性研究
[Translation] Study on the pharmacokinetics and safety of QR12000 compound tablets in participants with renal impairment and normal renal function
CTR20253455
QR12000复方片在肝功能损害和肝功能正常参与者中的药代动力学和安全性研究
[Translation] Study on the pharmacokinetics and safety of QR12000 compound tablets in participants with hepatic impairment and normal hepatic function
NCT06716970
A Multicenter, Randomized, Double-blind, and Active-controlled Parallel Study to Evaluate the Efficacy and Safety of QR12000 Compound Tablets and Sacubitril/valsartan Tablets in Patients with Moderate to Severe Essential Hypertension
100 Clinical Results associated with QR-12000
Login to view more data
100 Translational Medicine associated with QR-12000
Login to view more data
100 Patents (Medical) associated with QR-12000
Login to view more data
100 Deals associated with QR-12000
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | China | 10 Sep 2025 | |
| Essential Hypertension | Phase 3 | China | 16 Dec 2024 | |
| Heart Failure | Phase 2 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free